Advances in the treatment of tuberculosis

Y. Zhang

Research output: Contribution to journalReview articlepeer-review

51 Scopus citations


The current 6-month tuberculosis (TB) therapy is suboptimal with significant side effects and a poor patient compliance problem that frequently selects drug-resistant organisms. The increasing drug-resistant TB problem highlights the need to develop new and more effective drugs. Significant progress has been made recently with several new drug candidates currently in clinical trials. Improved understanding of persister biology and development of persister drugs are likely to be important for developing a more effective therapy.

Original languageEnglish (US)
Pages (from-to)595-600
Number of pages6
JournalClinical pharmacology and therapeutics
Issue number5
StatePublished - Nov 2007

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Advances in the treatment of tuberculosis'. Together they form a unique fingerprint.

Cite this